ClinConnect ClinConnect Logo
Search / Trial NCT06723327

The Effect of Preoperative Culture Timing on Postoperative Outcomes of Retrograde Intrarenal Surgery

Launched by NAMIK KEMAL UNIVERSITY · Dec 4, 2024

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Urine Culture Urolithiasis Kidney Stone Retrograde Intrarenal Surgery

ClinConnect Summary

This clinical trial is studying how the timing of urine culture tests before retrograde intrarenal surgery (a procedure to remove kidney stones) affects the risk of complications after surgery, particularly infections. The goal is to find out the best time to take these urine tests to ensure they are still accurate and that the urine is clear of infection when patients go into surgery. Researchers want to compare urine cultures taken two weeks before the surgery with those taken as close to the surgery date as possible.

To participate in this study, patients need to be over 18 years old and must have had a urine culture taken two weeks before their surgery that showed no signs of infection. The trial is currently looking for participants, and it’s open to all genders. If you decide to join, you can expect to contribute to important research that could help improve surgical outcomes for future patients. It's important to know that certain individuals, such as those with specific kidney conditions or infections, may not be eligible for this trial.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patients over 18 years of age
  • Patients who had a urine culture taken 2 weeks before the operation and reported as sterile
  • Exclusion Criteria:
  • Patients under 18 years of age
  • Patients without sufficient data
  • Patients with a urine culture more than 2 weeks before retrograde intrarenal -surgery
  • Patients with a positive urine culture before retrograde intrarenal surgery
  • Patients with renal anatomic anomalies
  • Patients with a solitary (single) kidney

About Namik Kemal University

Namik Kemal University is a leading academic institution dedicated to advancing research and education in the health sciences. With a commitment to innovation and excellence, the university actively sponsors clinical trials aimed at enhancing patient care and developing new therapeutic approaches. Leveraging its state-of-the-art facilities and a team of experienced researchers, Namik Kemal University fosters collaborative partnerships that drive scientific discovery and contribute to the body of knowledge in clinical medicine. Through its rigorous research programs, the university aims to improve health outcomes and address pressing medical challenges, making a significant impact on both local and global health communities.

Locations

Tekirdağ, , Turkey

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported